MOONWALK BIOSCIENCES
Dead / Abandoned — Abandoned — no statement of use filed (as of 05 Sept 2025)
What this means for you
This application is over — abandoned 05 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98206109
- Mark type
- Stylized text
- Filed
- 02 Oct 2023
- Published for opposition
- 07 Jan 2025
- Abandoned
- 05 Sept 2025
- Attorney of record
- Michael J. Allan
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, psychiatric, pulmonary, renal, reproductive, respiratory, and skeletal diseases, age-related diseases in the nature of neurodegeneration, arthritis, cardiovascular disease, type 2 diabetes, cancer, and osteoporosis, and pediatric diseases in the nature of anemia, asthma, gastrointestinal disorders, skin conditions, neurological disorders, blood disorders, endocrine disorders, developmental or growth disorders, immunological disorders, obesity, and type 1 diabetes; Veterinary pharmaceutical preparations and substances for the treatment of autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, pulmonary, renal, reproductive, respiratory, and skeletal diseases, and age-related diseases in the nature of arthritis, thyroid imbalance, heart disease, kidney disease, cancer, endocrine disorders, liver disease, obesity, skin, respiratory, gastrointestinal and dental disease
Owner
- Moonwalk Biosciences, South San Francisco, CA, US
- Moonwalk Biosciences, South San Francisco, CA, US
Prosecution history
- 10 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 06 Mar 2026 — DIVISIONAL PROCESSING COMPLETE
- 11 Jul 2025 — DIVISIONAL REQUEST RECEIVED
- 06 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Jul 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION
- 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Dec 2024 — EXAMINER'S AMENDMENT ENTERED
- 12 Dec 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED